BeStock  
Stocks › Biotechnology › RGNX

Regenxbio RGNX

US equityMarket cap rank #3612Biotechnology
$7.16 −$0.02 (-0.28%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.12 -0.56%
Open$7.00
Prev close$7.18
Day range$6.86 – $7.30
Volume1.06M
Market cap$473.44M
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

RGNX at a glance

RGNX is priced at $7.16 right now, down 0.28% on the session. That puts its market value at $473.44M, 3612th largest among the 3753 stocks we cover.

Over the past 52 weeks it has traded between $5.46 and $16.19, so it sits 55.8% below the top of that range. Holders are behind 39.3% over twelve months, and down 11.1% across the last three months.

On the chart it has slipped under both the 50-day ($7.51) and 200-day ($8.79) moving averages; RSI is 45, and the last 30 sessions moved at roughly 72% annualized volatility.

For the quarter ended Sep 2026 it reported $9.16M in revenue, down 69.2% from a year earlier, and a net loss of $40.74M.

11 analysts follow the stock and the average call is "buy". The mean target, $20.91, sits 192.0% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$6.80 / $7.12
Average price today$7.12
Volume1.06MAvg (90d) 1.40M
Turnover$7.57M
Turnover rate1.88%of shares outstanding
Volume ratio1.29vs. recent average pace
Day amplitude6.13%
Market cap$473.44M
Float market cap$405.49M
Shares outstanding56.63M
EPS (TTM)-$3.76
P/B3.20
Book value / share$2.24
Net profit (TTM)-$248.62M
Net assets$148.05M
30-day volatility71.6%annualized
Avg daily range (ATR)8.49%of price, 14 days
Max drawdown (1y)-64.6%-55.2% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

D
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

C
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

11 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 40.1 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth70.4
Profitability16.6
Momentum19.4
Financial health40.2
Analyst view87.4

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$20.91+192.0% vs. current price
Consensus ratingBuy11 analysts covering
Morningstar fair value$10.36Price is below fair value

Wall Street’s average 12-month target is $20.91, 192.0% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $10.36, so shares trade 30.9% below that estimate. On earnings multiple, it sits in the 50th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-0.3%
1 week
-6.3%
1 month
-0.1%
3 months
-11.1%
6 months
+12.8%
Year to date
-50.3%
1 year
-39.3%
Day range
$6.86$7.30
52-week range
$5.46$16.19

Technical signals

Full technicals →
Trend readStrong downtrend

0 bullish · 7 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-3.6%Bearish
Price vs 50-day average-4.6%Bearish
Price vs 200-day average-18.5%Bearish
50-day vs 200-day50d below 200dBearish
RSI (14)44.9Bearish
MACD (12,26,9)-0.06Bearish
Bollinger band position35%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How RGNX ranks on BeStock

Market value#3594 of 3734
Closeness to 52-week high#3205 of 3724
Dollar volume today#2535 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

RGNX is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on RGNX.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on RGNX

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

RGNX stock: common questions

Where is RGNX trading right now?

$7.16 is the latest print for RGNX, a move of -0.28% against yesterday's close of $7.18. Today's low and high so far: $6.86 and $7.30.

How large is Regenxbio by market value?

Equity value comes to $473.44M at the current price. By that measure it is number 3612 of the 3753 names in our coverage.

Is RGNX near its 52-week high or low?

The year's floor is $5.46 and the ceiling $16.19. Shares are 55.8% away from that ceiling.

Does Regenxbio pay a dividend?

Our data shows no dividend paid by Regenxbio over the trailing twelve months.

Is RGNX rated a buy by Wall Street?

Of 11 analysts, 82% say buy, 18% hold and 0% sell. Price targets average $20.91, with the most cautious at $10.00 and the most optimistic at $42.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on RGNX.

Sign in to join the discussion.

Scroll to Top